1Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases[J]. Nature, 2000, 407(6801): 249-257.
2Pooh R.T,Fan ST,Wong J.Clinical implications of circulating angiogenic factors in cancer parients[J].J Clin Oncol, 2001,19(4):1207-1225.
3Ferrara N, VEGF and the quest for tumour angiogenesis factors[J]. Nat Rev Cancer, 2002, 2(10): 795-803.
4Hua Lu, Xiao-Ou Shu, Yong Cui, et al. Association of Genetic Polymorphisms in the VEGF Gene with Breast Cancer Survival[J].Cancer Research, 2005, 65(12): 5015 -5019.
5Jacobs E, Feigelson I-l, Bain E,et al.Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study ].I cohort[J]. Breast Cancer R_es,2006,8(2):22.
6Ferrara N. Vascular endothelial growth factor: Molecular and biological aspects[J]. To!0 icsMicrobiol Immunol. 1999.237:1 - 30.
8Lambrechts D, Storkebaum E, Mofimoto M,et al. VEGF is a modifier of amyotropbic lateral sclerosis in mice and hmnans and protects motoneurons against iscbemic death[J]. Nat Genet, 2003, 34(4): 383-394.
9Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection[J].J Am Soc Nephrol, 2002, 13(1): 260 - 264.
10Howell WM, Bateman AC, Turner SJ, et al. Influence of vascular endothelial growth factor single nucleotide polymorphisms on turnout development in cutaneous malignant melanoma[J]. Genes Immun, 2002, 3(4):229 - 232.
